Evaluation of a New CZT System

The recruitment status of this study is unknown because the information has not been verified recently.

Verified March 2010 by Tel-Aviv Sourasky Medical Center.
Recruitment status was Not yet recruiting

Sponsor:

Information provided by:

Tel-Aviv Sourasky Medical Center

ClinicalTrials.gov Identifier:

NCT01084356

First received: March 9, 2010

Last updated: NA

Last verified: March 2010

History: No changes posted

Purpose

The purpose of the study is to check if the new CZT system has an advantage in detection of small osseous processes, thyroid adenomas, parathyroid adenomas and detection of sentinel node, in comparison with the techniques in use.

Participants: 100 subjects male and female that come to the institute of nuclear medicine for routine screening examinations.

The CZT screening takes 10 minutes and does not require any extra intervention to the routine screening.

Condition
Parathyroid Adenoma Thyroid Adenoma

Study Type:	Observational
Study Design:	Observational Model: Cohort Time Perspective: Prospective
Official Title:	Evaluation of a New CZT System for Imaging in Routine Nuclear Medicine Examination

Resource links provided by NLM:

MedlinePlus related topics: Nuclear Scans Thyroid Diseases

U.S. FDA Resources

Further study details as provided by Tel-Aviv Sourasky Medical Center:

Estimated Enrollment:	100
Study Start Date:	March 2010
Estimated Primary Completion Date:	March 2011 (Final data collection date for primary outcome measure)

Groups/Cohorts
hand patients admitted for Tc MDP for evaluation of carpal/metacarpal and finger bone lesions
thyroid patients admitted for Tc thyroid scan
parathyroid patients investigated for parathyroid adenoma
sentinel node patients who are due to sentinel node biopsy

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	Yes
Sampling Method:	Non-Probability Sample

Study Population

consequtive patiants admitted for the above scans and consented to be further investigated by the CZT system

Criteria

Inclusion Criteria:

age over 18

Exclusion Criteria:

pregnancy
patients unable to understand and sign an informed consent
age under 18

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT01084356

Contacts

Contact: Einat Even Sapir, PhD,MD	972-3-6974444 ext 3536	evensap@tasmc.health.gov.il
Contact: Ayelet Kurzband, BA	972-3-6974444 ext 3536	ayeletk@tasmc.health.gov.il

Locations

Israel
Department of Nuclear Medicine, Tel Aviv Sourasky Medical Center	Not yet recruiting
Tel Aviv, Israel
Contact: Einat Even Sapir, PhD, MD 972-3-6974444 ext 3536 evensap@tasmc.health.gov.il
Contact: Ayelet Kurzband, BA 972-3-6974444 ext 3536 ayeletk@tasmc.health.gov.il
Sub-Investigator: Hedva Lerman, MD
Principal Investigator: Einat Even-Sapir, MD, PhD

Sponsors and Collaborators

Tel-Aviv Sourasky Medical Center

Investigators

Principal Investigator:

Einat Even Sapir, PhD, MD

Tel Aviv Sourasky Medical Center, Tel Aviv, Israel

More Information

Publications:

Gambhir SS, Berman DS, Ziffer J, Nagler M, Sandler M, Patton J, Hutton B, Sharir T, Haim SB, Haim SB. A novel high-sensitivity rapid-acquisition single-photon cardiac imaging camera. J Nucl Med. 2009 Apr;50(4):635-43.

Hruska CB, Phillips SW, Whaley DH, Rhodes DJ, O'Connor MK. Molecular breast imaging: use of a dual-head dedicated gamma camera to detect small breast tumors. AJR Am J Roentgenol. 2008 Dec;191(6):1805-15.

Mueller B, O'Connor MK, Blevis I, Rhodes DJ, Smith R, Collins DA, Phillips SW. Evaluation of a small cadmium zinc telluride detector for scintimammography. J Nucl Med. 2003 Apr;44(4):602-9.

Ketchum LE. New equipment in nuclear medicine, part 1: solid-state detectors. J Nucl Med. 1998 Nov;39(11):15N, 35N-36N. No abstract available.

Rhodes DJ, O'Connor MK, Phillips SW, Smith RL, Collins DA. Molecular breast imaging: a new technique using technetium Tc 99m scintimammography to detect small tumors of the breast. Mayo Clin Proc. 2005 Jan;80(1):24-30.

O'Connor MK, Phillips SW, Hruska CB, Rhodes DJ, Collins DA. Molecular breast imaging: advantages and limitations of a scintimammographic technique in patients with small breast tumors. Breast J. 2007 Jan-Feb;13(1):3-11.

Tsuchimochi M, Hayama K, Oda T, Togashi M, Sakahara H. Evaluation of the efficacy of a small CdTe gamma-camera for sentinel lymph node biopsy. J Nucl Med. 2008 Jun;49(6):956-62. Epub 2008 May 15.

Responsible Party:	Einat Even-Sapir MD, PhD. Head, Dept of Nuclear Medicine, Tel Aviv SoUrasky medical center
ClinicalTrials.gov Identifier:	NCT01084356 History of Changes
Other Study ID Numbers:	TASMC-10-EES-0649-CTIL
Study First Received:	March 9, 2010
Last Updated:	March 9, 2010
Health Authority:	Israel: Ministry of Health

Keywords provided by Tel-Aviv Sourasky Medical Center:

CZT
sentinel node
osseous processes

Additional relevant MeSH terms:

Adenoma
Thyroid Neoplasms
Parathyroid Neoplasms
Neoplasms, Glandular and Epithelial
Neoplasms by Histologic Type
Neoplasms

Endocrine Gland Neoplasms
Neoplasms by Site
Head and Neck Neoplasms
Endocrine System Diseases
Thyroid Diseases
Parathyroid Diseases

ClinicalTrials.gov processed this record on May 19, 2013

To Top